Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: Efficacy and cardiac safety from the GEICAM/2004-05 study

  1. Martín, M.
  2. Sánchez-Rovira, P.
  3. Muñoz, M.
  4. Baena-Cañada, J.M.
  5. Mel, J.R.
  6. Margeli, M.
  7. Ramos, M.
  8. Martínez, E.
  9. García-Saenz, J.A.
  10. Casado, A.
  11. Jaén, A.M.
  12. González-Farré, X.
  13. Escudero, M.J.
  14. Rodriguez-Martin, C.
  15. Carrasco, E.
Aldizkaria:
Annals of Oncology

ISSN: 0923-7534,  1569-8041

Argitalpen urtea: 2011

Alea: 22

Zenbakia: 12

Orrialdeak: 2591-2596

Mota: Artikulua

DOI: 10.1093/ANNONC/MDR024 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus